Selective activation of the hypothalamic vasopressinelgic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids

被引:81
作者
Müller, MB
Landgraf, R
Preil, J
Sillaber, I
Kresse, AE
Keck, ME
Zimmermann, S
Holsboer, F
Wurst, W
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
[2] GSF Munich, Res Ctr, Inst Mammalian Genet, D-85764 Munich, Germany
[3] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Biol, Stockholm, Sweden
关键词
D O I
10.1210/en.141.11.4262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deficiency of CRH receptor 1 (CRHR1) severely impairs the stress response of the hypothalamic-pituitary-adrenocortical (HPA) system and reduces anxiety-related behavior in mice. Intriguingly, in mice deficient for the CRHR1 (Crhr1(-/-)), basal plasma levels of ACTH are normal, suggesting the presence of compensatory mechanisms for pituitary ACTH secretion. We therefore studied the impact of the hypothalamic neuropeptides arginine vasopressin (AVP) and oxytocin (OXT) on HPA system regulation in homozygous and heterozygous Crhr1 mutants under basal and different stress conditions. Basal plasma AVP concentrations were significantly elevated in Crhr1(-/-) mice. AW messenger RNA expression was increased in the paraventricular nucleus of Crhr1(-/-) mutants together with a marked increase in AW-like immunoreactivity in the median eminence. Administration of an AVP V-1-receptor antagonist significantly decreased basal plasma ACTH levels in mutant mice. After continuous treatment with corticosterone, plasma AVP levels in homozygous Crhr1(-/-) mice were indistinguishable from those in wild-type littermates, thus providing evidence that glucocorticoid deficiency is the major driving force behind compensatory activation of the vasopressinergic system in Crhr1(-/-) mice. Neither plasma OXT levels under several different conditions nor OXT messenger RNA expression in the paraventricular nucleus were different between the genotypes. Taken together, our data reveal a selective compensatory activation of the hypothalamic vasopressinergic, but not the oxytocinergic system, to maintain basal ACTH secretion and HPA system activity in Crhr1(-/-) mutants.
引用
收藏
页码:4262 / 4269
页数:8
相关论文
共 48 条
[1]   VASOPRESSINERGIC CONTROL OF PITUITARY ADRENOCORTICOTROPIN SECRETION COMES OF AGE [J].
ANTONI, FA .
FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (02) :76-122
[2]   NOVEL LIGAND SPECIFICITY OF PITUITARY VASOPRESSIN RECEPTORS IN THE RAT [J].
ANTONI, FA .
NEUROENDOCRINOLOGY, 1984, 39 (02) :186-188
[3]   THE NEUROPHYSIN-CONTAINING INNERVATION OF THE FOREBRAIN OF THE MOUSE [J].
CASTEL, M ;
MORRIS, JF .
NEUROSCIENCE, 1988, 24 (03) :937-966
[4]   Corticotrophin-releasing factor receptors: From molecular biology to drug design [J].
Chalmers, DT ;
Lovenberg, TW ;
Grigoriadis, DE ;
Behan, DP ;
DeSouza, EB .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (04) :166-172
[5]  
Chen JC, 2000, J COMP NEUROL, V420, P305, DOI 10.1002/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO
[6]  
2-8
[7]   CHRONIC PSYCHOSOCIAL STRESS ENHANCES VASOPRESSIN, BUT NOT CORTICOTROPIN-RELEASING FACTOR, IN THE EXTERNAL ZONE OF THE MEDIAN-EMINENCE OF MALE-RATS - RELATIONSHIP TO SUBORDINATE STATUS [J].
DEGOEIJ, DCE ;
DIJKSTRA, H ;
TILDERS, FJH .
ENDOCRINOLOGY, 1992, 131 (02) :847-853
[8]   Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders [J].
DeSouza, EB .
PSYCHONEUROENDOCRINOLOGY, 1995, 20 (08) :789-819
[9]  
Dijkstra I, 1998, J NEUROSCI, V18, P3909
[10]   CORTICOTROPIN RELEASING ACTIVITY OF THE NEW CRF IS POTENTIATED SEVERAL TIMES BY VASOPRESSIN [J].
GILLIES, GE ;
LINTON, EA ;
LOWRY, PJ .
NATURE, 1982, 299 (5881) :355-357